Cargando…

Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution

BACKGROUND: There are limited data available concerning endofistular therapies for fistula-in-ano, with our group reporting the first preliminary outcomes of the use of the radial fibre Fistula laser Closing (FiLaC ™) device. METHODS: The aim of this study was to assess a cohort of anal fistulae man...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilhelm, A., Fiebig, A., Krawczak, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423928/
https://www.ncbi.nlm.nih.gov/pubmed/28271331
http://dx.doi.org/10.1007/s10151-017-1599-7
_version_ 1783235025260511232
author Wilhelm, A.
Fiebig, A.
Krawczak, M.
author_facet Wilhelm, A.
Fiebig, A.
Krawczak, M.
author_sort Wilhelm, A.
collection PubMed
description BACKGROUND: There are limited data available concerning endofistular therapies for fistula-in-ano, with our group reporting the first preliminary outcomes of the use of the radial fibre Fistula laser Closing (FiLaC ™) device. METHODS: The aim of this study was to assess a cohort of anal fistulae managed with laser ablation plus definitive flap closure of the internal fistula opening over a long-term follow-up. Factors governing primary healing success and secondary healing success (i.e. success after one or two operations) were determined. RESULTS: The study analysed 117 patients over a median follow-up period of 25.4 months (range 6–60 months) with 13 patients (11.1%) having Crohn’s-related fistulae. No incontinence to solid and liquid stool was reported. Minor incontinence to mucus and gas was observed in two cases (1.7%), and a late abscess treated in one case (0.8%). The primary healing rate was 75/117 (64.1%) overall, and 63.5% for cryptoglandular fistulae versus 69.2% for Crohn’s fistulae, respectively. Of the 42 patients who failed FiLaC™ 31 underwent a second operation (“Re-FiLaC™”, fistulectomy with sphincter reconstruction or fistulotomy). The secondary healing rate, defined as healing of the fistula at the end of the study period, was 103/117 (88.0%) overall and 85.5% for cryptoglandular fistulae versus 92.3% for Crohn’s fistulae. A significantly higher primary success rate was observed for intersphincteric-type fistulae with primary and secondary outcome unaffected by age, gender, presence of Crohn’s disease, number of prior surgeries and the type of flap designed to close the internal fistula opening. CONCLUSIONS: There is a moderate primary success rate using first-up FiLaC™ treatment. If FiLaC™ fails, secondary success with repeat FiLaC™ or other approaches was high. The minimally invasive FiLaC™ approach may therefore represent a sensible first-line treatment option for anal fistula repair.
format Online
Article
Text
id pubmed-5423928
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-54239282017-05-25 Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution Wilhelm, A. Fiebig, A. Krawczak, M. Tech Coloproctol Original Article BACKGROUND: There are limited data available concerning endofistular therapies for fistula-in-ano, with our group reporting the first preliminary outcomes of the use of the radial fibre Fistula laser Closing (FiLaC ™) device. METHODS: The aim of this study was to assess a cohort of anal fistulae managed with laser ablation plus definitive flap closure of the internal fistula opening over a long-term follow-up. Factors governing primary healing success and secondary healing success (i.e. success after one or two operations) were determined. RESULTS: The study analysed 117 patients over a median follow-up period of 25.4 months (range 6–60 months) with 13 patients (11.1%) having Crohn’s-related fistulae. No incontinence to solid and liquid stool was reported. Minor incontinence to mucus and gas was observed in two cases (1.7%), and a late abscess treated in one case (0.8%). The primary healing rate was 75/117 (64.1%) overall, and 63.5% for cryptoglandular fistulae versus 69.2% for Crohn’s fistulae, respectively. Of the 42 patients who failed FiLaC™ 31 underwent a second operation (“Re-FiLaC™”, fistulectomy with sphincter reconstruction or fistulotomy). The secondary healing rate, defined as healing of the fistula at the end of the study period, was 103/117 (88.0%) overall and 85.5% for cryptoglandular fistulae versus 92.3% for Crohn’s fistulae. A significantly higher primary success rate was observed for intersphincteric-type fistulae with primary and secondary outcome unaffected by age, gender, presence of Crohn’s disease, number of prior surgeries and the type of flap designed to close the internal fistula opening. CONCLUSIONS: There is a moderate primary success rate using first-up FiLaC™ treatment. If FiLaC™ fails, secondary success with repeat FiLaC™ or other approaches was high. The minimally invasive FiLaC™ approach may therefore represent a sensible first-line treatment option for anal fistula repair. Springer International Publishing 2017-03-07 2017 /pmc/articles/PMC5423928/ /pubmed/28271331 http://dx.doi.org/10.1007/s10151-017-1599-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Wilhelm, A.
Fiebig, A.
Krawczak, M.
Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title_full Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title_fullStr Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title_full_unstemmed Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title_short Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution
title_sort five years of experience with the filac™ laser for fistula-in-ano management: long-term follow-up from a single institution
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423928/
https://www.ncbi.nlm.nih.gov/pubmed/28271331
http://dx.doi.org/10.1007/s10151-017-1599-7
work_keys_str_mv AT wilhelma fiveyearsofexperiencewiththefilaclaserforfistulainanomanagementlongtermfollowupfromasingleinstitution
AT fiebiga fiveyearsofexperiencewiththefilaclaserforfistulainanomanagementlongtermfollowupfromasingleinstitution
AT krawczakm fiveyearsofexperiencewiththefilaclaserforfistulainanomanagementlongtermfollowupfromasingleinstitution